BIOMAT Database Logo BIOMAT Database Logo

[Immunohistochemical studies on epidermal growth factor receptor in experimental squamous cell carcinoma of the uterine cervix of mice]. 1988

M Ueda, and Y Yanagawa, and Y Okamoto, and T Yamada, and O Misaki, and Y Seiki, and T Tsurunaga, and E Iwai, and M Ueki, and O Sugimoto
Department of Obstetrics and Gynecology, Osaka Medical College.

The tissue localization of epidermal growth factor receptor (EGF-R) in experimental squamous cell carcinoma of the mouse uterine cervix was examined immunohistochemically. Carcinoma was induced by the insertion of a 20-methylcholanthrene (MC)-impregnated thread into the cervical canal of the mouse. Tissue sections (of normal columnar epithelium, proliferation, atypical proliferation, early invasive carcinoma, invasive carcinoma and metastatic carcinoma) were stained by the avidin/biotin immunoperoxidase technique using anti-EGF-R monoclonal antibody. Normal columnar epithelium was negative for EGF-R, whereas proliferation was partly positive. The lesions of atypical proliferation and early invasive carcinoma had a positive staining for EGF-R. The staining for EGF-R declined in the lesion of invasive carcinoma. Metastatic carcinoma was not stained for EGF-R. These results suggest that EGF-R may play an important role in the early stage of carcinogenesis of the mouse uterine cervix induced by 20-MC.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008748 Methylcholanthrene A carcinogen that is often used in experimental cancer studies. 20-Methylcholanthrene,3-Methylcholanthrene,20 Methylcholanthrene,3 Methylcholanthrene
D008813 Mice, Inbred ICR An inbred strain of mouse that is used as a general purpose research strain, for therapeutic drug testing, and for the genetic analysis of CARCINOGEN-induced COLON CANCER. Mice, Inbred ICRC,Mice, ICR,Mouse, ICR,Mouse, Inbred ICR,Mouse, Inbred ICRC,ICR Mice,ICR Mice, Inbred,ICR Mouse,ICR Mouse, Inbred,ICRC Mice, Inbred,ICRC Mouse, Inbred,Inbred ICR Mice,Inbred ICR Mouse,Inbred ICRC Mice,Inbred ICRC Mouse
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D002294 Carcinoma, Squamous Cell A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed) Carcinoma, Epidermoid,Carcinoma, Planocellular,Carcinoma, Squamous,Squamous Cell Carcinoma,Carcinomas, Epidermoid,Carcinomas, Planocellular,Carcinomas, Squamous,Carcinomas, Squamous Cell,Epidermoid Carcinoma,Epidermoid Carcinomas,Planocellular Carcinoma,Planocellular Carcinomas,Squamous Carcinoma,Squamous Carcinomas,Squamous Cell Carcinomas
D002583 Uterine Cervical Neoplasms Tumors or cancer of the UTERINE CERVIX. Cancer of Cervix,Cancer of the Cervix,Cancer of the Uterine Cervix,Cervical Cancer,Cervical Neoplasms,Cervix Cancer,Cervix Neoplasms,Neoplasms, Cervical,Neoplasms, Cervix,Uterine Cervical Cancer,Cancer, Cervical,Cancer, Cervix,Cancer, Uterine Cervical,Cervical Cancer, Uterine,Cervical Cancers,Cervical Neoplasm,Cervical Neoplasm, Uterine,Cervix Neoplasm,Neoplasm, Cervix,Neoplasm, Uterine Cervical,Uterine Cervical Cancers,Uterine Cervical Neoplasm
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D066246 ErbB Receptors A family of structurally related cell-surface receptors that signal through an intrinsic PROTEIN-TYROSINE KINASE. The receptors are activated upon binding of specific ligands which include EPIDERMAL GROWTH FACTORS, and NEUREGULINS. EGF Receptor,Epidermal Growth Factor Receptor,Epidermal Growth Factor Receptor Family Protein,Epidermal Growth Factor Receptor Protein-Tyrosine Kinase,ErbB Receptor,HER Family Receptor,Receptor, EGF,Receptor, Epidermal Growth Factor,Receptor, TGF-alpha,Receptor, Transforming-Growth Factor alpha,Receptor, Urogastrone,Receptors, Epidermal Growth Factor-Urogastrone,TGF-alpha Receptor,Transforming Growth Factor alpha Receptor,Urogastrone Receptor,c-erbB-1 Protein,erbB-1 Proto-Oncogene Protein,EGF Receptors,Epidermal Growth Factor Receptor Family Proteins,Epidermal Growth Factor Receptor Kinase,HER Family Receptors,Proto-oncogene c-ErbB-1 Protein,Receptor Tyrosine-protein Kinase erbB-1,Receptor, ErbB-1,Receptors, Epidermal Growth Factor,Epidermal Growth Factor Receptor Protein Tyrosine Kinase,ErbB-1 Receptor,Family Receptor, HER,Family Receptors, HER,Proto oncogene c ErbB 1 Protein,Proto-Oncogene Protein, erbB-1,Receptor Tyrosine protein Kinase erbB 1,Receptor, ErbB,Receptor, ErbB 1,Receptor, HER Family,Receptor, TGF alpha,Receptor, Transforming Growth Factor alpha,Receptors, EGF,Receptors, Epidermal Growth Factor Urogastrone,Receptors, ErbB,Receptors, HER Family,c erbB 1 Protein,c-ErbB-1 Protein, Proto-oncogene,erbB 1 Proto Oncogene Protein

Related Publications

M Ueda, and Y Yanagawa, and Y Okamoto, and T Yamada, and O Misaki, and Y Seiki, and T Tsurunaga, and E Iwai, and M Ueki, and O Sugimoto
[Immunohistochemical studies on epidermal growth factor receptor and the myc oncogene product in squamous cell carcinoma of the uterine cervix].
January 1988, Nihon Sanka Fujinka Gakkai zasshi,
M Ueda, and Y Yanagawa, and Y Okamoto, and T Yamada, and O Misaki, and Y Seiki, and T Tsurunaga, and E Iwai, and M Ueki, and O Sugimoto
Clinical implications of the epidermal growth factor receptor in the squamous cell carcinoma of the uterine cervix.
May 1989, Gynecologic oncology,
M Ueda, and Y Yanagawa, and Y Okamoto, and T Yamada, and O Misaki, and Y Seiki, and T Tsurunaga, and E Iwai, and M Ueki, and O Sugimoto
[Immunohistochemical studies on epidermal growth factor receptor in hepatocellular carcinoma].
February 1991, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology,
M Ueda, and Y Yanagawa, and Y Okamoto, and T Yamada, and O Misaki, and Y Seiki, and T Tsurunaga, and E Iwai, and M Ueki, and O Sugimoto
[Immunohistochemical study of epidermal growth factor receptor expression in esophageal squamous cell carcinoma].
January 2010, Arkhiv patologii,
M Ueda, and Y Yanagawa, and Y Okamoto, and T Yamada, and O Misaki, and Y Seiki, and T Tsurunaga, and E Iwai, and M Ueki, and O Sugimoto
[Immunohistochemical studies on epidermal growth factor receptor in oncogenesis of uterine cervical cancer].
September 1989, Nihon Sanka Fujinka Gakkai zasshi,
M Ueda, and Y Yanagawa, and Y Okamoto, and T Yamada, and O Misaki, and Y Seiki, and T Tsurunaga, and E Iwai, and M Ueki, and O Sugimoto
Immunohistochemical Expression of Epidermal Growth Factor Receptor in Head and Neck Squamous Cell Carcinoma.
April 2017, Journal of the College of Physicians and Surgeons--Pakistan : JCPSP,
M Ueda, and Y Yanagawa, and Y Okamoto, and T Yamada, and O Misaki, and Y Seiki, and T Tsurunaga, and E Iwai, and M Ueki, and O Sugimoto
Immunohistochemical study of epidermal growth factor receptor, human epidermal growth factor receptor 2/neu, p53, and Ki67 in oral squamous cell carcinoma.
January 2022, Journal of oral and maxillofacial pathology : JOMFP,
M Ueda, and Y Yanagawa, and Y Okamoto, and T Yamada, and O Misaki, and Y Seiki, and T Tsurunaga, and E Iwai, and M Ueki, and O Sugimoto
[Immunohistochemical study on keratin of squamous cell carcinoma of the uterine cervix].
January 1992, Nihon Sanka Fujinka Gakkai zasshi,
M Ueda, and Y Yanagawa, and Y Okamoto, and T Yamada, and O Misaki, and Y Seiki, and T Tsurunaga, and E Iwai, and M Ueki, and O Sugimoto
Absence of epidermal growth factor receptor expression in squamous cell carcinoma of the uterine cervix is an indicator of limited tumor disease.
January 1999, Oncology reports,
M Ueda, and Y Yanagawa, and Y Okamoto, and T Yamada, and O Misaki, and Y Seiki, and T Tsurunaga, and E Iwai, and M Ueki, and O Sugimoto
Expression of epidermal growth factor receptor on oral squamous cell carcinoma.
October 1988, The British journal of oral & maxillofacial surgery,
Copied contents to your clipboard!